Crossmark

Cost-effectiveness analysis of tranexamic acid for the treatment of traumatic brain injury, based on the results of the CRASH-3 randomised trial: a decision modelling approach

Crossref DOI link: https://doi.org/10.1136/bmjgh-2020-002716

Published Online: 2020-09-02

Published Print: 2020-09

Update policy: https://doi.org/10.1136/crossmarkpolicy

Authors

Williams, Jack https://orcid.org/0000-0002-1331-387X
Roberts, Ian

Shakur-Still, Haleema

Lecky, Fiona E

Chaudhri, Rizwana

Miners, Alec
Funding

Funding for this research was provided by:

JP Moulton Charitable Trust

Joint Global Health 1 Trials

Health Technology Assessment Programme
License Information

License valid from 2020-09-02

Document is current

Any future updates will be listed below